| FD | Fabry disease |
| GLA | Galactosidase alpha |
| Gb3 | Globotriaosylceramide |
| Lyso-Gb3 | Globotriaosylsphingosine |
| ESKD | End-stage kidney disease |
| VUS | Variants of unknown significance |
| AS | Alport syndrome |
| GBM | Glomerular basement membrane |
| XLAS | X-linked Alport syndrome |
| ADAS | Autosomal dominant Alport syndrome |
| ARAS | Autosomal recessive Alport syndrome |
| AMI | Acute myocardial infarction |
| ERT | Enzyme replacement therapy |
| ACE | Angiotensin-converting enzyme |
| MRI | Magnetic resonance imaging |
| IVS | Interventricular septum |
| PNS | Peripheral nervous system |
| eGFR | Estimated glomerular filtration rate |